Article
Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.
Journal of neuro-oncology - 1 Mar 2012
Nord Helena, Pfeifer Susan, Nilsson Pelle, Sandgren Johanna, Popova Svetlana, Strömberg Bo, Alafuzoff Irina, Nistér Monica, Díaz de Ståhl Teresita
Abstract excerpt
Medulloblastoma (MB) is a WHO grade IV, invasive embryonal CNS tumor that mainly affects children. The aggressiveness and response to therapy can vary considerably between cases, and despite treatment, ~30% of patients die within 2 years from diagnosis. Furthermore, the majority of survivors suffer long-term side-effects due to severe management modalities. Several distinct morphological features have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
